stockrowNatera, Inc.
NTRA Healthcare Diagnostics & Research
Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024.
- Revenue
- +34.1%
- EPS
- +34.4%
- Free cash flow
- −85.8%
- Total debt
- −0.06%
Quarter to September 2026, against a year earlier
Follow NTRA
Alert me
Natera, Inc. (NTRA) Operating cash flow
Natera, Inc.'s operating cash flow for fiscal 2025 was $215.3M, up 58.7% from $135.7M in fiscal 2024. Over the twelve months to 30 September 2026 it was $212.8M. Over the past ten years it has ranged from −$431.5M (fiscal 2022) to $215.3M (fiscal 2025) — the current reading is the highest in ten years. Operating cash flow has risen for 3 consecutive fiscal years. Natera, Inc. ranks 18th of 49 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $215.3M | 58.70% |
| FY2024 | $135.7M | — |
| FY2023 | −$247.0M | — |
| FY2022 | −$431.5M | — |
| FY2021 | −$335.2M | — |
| FY2020 | −$182.5M | — |
| FY2019 | −$63.4M | — |
| FY2018 | −$70.6M | — |
| FY2017 | −$97.8M | — |
| FY2016 | −$74.1M | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $43.9M | (19.82%) |
| Jun 2026 | $54.8M | 36.40% |
| Mar 2026 | $40.2M | (45.63%) |
| Dec 2025 | $73.9M | 24.42% |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| IQV IQVIA Holdings Inc. compare | $2.7B |
| DGX Quest Diagnostics Incorporated compare | $2.0B |
| LH Labcorp Holdings Inc. compare | $1.8B |
| A Agilent Technologies, Inc. compare | $1.6B |
| IDXX IDEXX Laboratories, Inc. compare | $1.4B |
| ILMN Illumina, Inc. compare | $1.2B |
| MTD Mettler-Toledo International, Inc. compare | $975.2M |
| WAT Waters Corporation compare | $460.6M |
| NTRA Natera, Inc. | $212.8M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on NTRA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement